Advanced renal or liver disease; Active cancer; Known Hypersensitivity reaction to Plasma-derived drugs; Pregnancy; Lactation; The patient may be excluded from the study during the first 48 hours.

Advanced renal or liver disease; Active cancer; Known Hypersensitivity reaction to Plasma-derived drugs; Pregnancy; Lactation; The patient may be excluded from the study during the first 48 hours.